Table 1 Characteristics of participants

Female (%, n)

67% (212)

68% (106)

0.9

Age (years, mean, standard deviation)

39.3 (10.9)

40.0 (11.8)

0.7

CD4 (most recent, mean, standard deviation)

373 (204)

407 (206)

0.2

Weight (kg, most recent, mean, standard deviation)

62.7 (10.9)

64.8 (12.4)

0.07

Stage IV at start of ART (%, n)

20% (64)

22% (35)

0.6

Time on ART at start (days, mean, standard deviation)

347 (278)

506 (334)

< 0.0001

Length of follow-up (days, mean, standard deviation)

267 (48)

242 (53)

< 0.0001